Source: Atherosclerosis Supplements. Unidade: FM
Subjects: DOENÇAS RARAS, DOENÇAS GENÉTICAS, LIPOPROTEÍNAS LDL, ARTERIOSCLEROSE (DIAGNÓSTICO)
ABNT
SANTOS, Raul D. What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs?. Atherosclerosis Supplements, v. 15, n. 2, p. 19-25, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosissup.2014.07.003. Acesso em: 24 abr. 2024.APA
Santos, R. D. (2014). What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs? Atherosclerosis Supplements, 15( 2), 19-25. doi:10.1016/j.atherosclerosissup.2014.07.003NLM
Santos RD. What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs? [Internet]. Atherosclerosis Supplements. 2014 ; 15( 2): 19-25.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.atherosclerosissup.2014.07.003Vancouver
Santos RD. What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs? [Internet]. Atherosclerosis Supplements. 2014 ; 15( 2): 19-25.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.atherosclerosissup.2014.07.003